Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0030193 (pain)
 261,466 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Eight cases of primary malignant giant cell tumor of bone were reviewed. There was a wide range in age from 17 to 76 years, with the sixth decade of life being the most common. The tumor was more frequent among females (male to female ratio--3:5). The most common sites of occurrence were in the region of the knee, with the distal end of femur and the proximal end of tibia affected in three and two cases, respectively. Pain and swelling of the involved regions were the most common complaints. The roentgenographic and pathologic features and the treatment were analyzed in detail. Although these cases were considered malignant, the follow-up periods varying from 4 to 15 years were available in six of the eight cases; only one patient died of tumor, 8 months after the surgical procedure. One patient died of unrelated cause, but the others were all alive with no evidence of disease. The pertinent literature was analyzed and examples of secondary malignant giant cell tumors of bone were compared to those of this present series to delineate differences in natural history and clinicopathologic features. It was clearly established that primary malignant giant cell tumor of bone is a separate entity with a more favorable clinical behavior, particularly if the disease process is eradicated early on either by cryosurgery, en bloc radical resection, or amputation.
Cancer 1979 Oct
PMID:Primary malignant giant cell tumor of bone: a study of eight cases and review of the literature. 22 63

While synovial sarcoma most commonly presents as a painless mass, occasionally the cancer emerges in a misleading manner resulting in an unfavorable delay or error in diagnosis. A review of the litrature reveals 4 such occult patterns: pretumor phase characterized only by pain or tenderness; the acute inflammatory lesion presenting as a "hot" arthritis or bursitis; the chronic contracture; the post traumatic tumor. These conditions, especially when otherwise unaccounted for, are indications for biopsy. Four avoidable pitfalls in biopsy management also emerged from the review.
 ...
PMID:The early clinical presentation of synovial sarcoma. 22 35

This article describes 41 examples of an unusual fibrohistiocytic sarcoma which occurred primarily in the extremities of young individuals between the ages of 5 and 25 years (median 13 years). It manifested as a nodular subcutaneous growth that seldom caused tenderness or pain, and clinically was often mistaken for a hematoma or a hemangioma. Grossly, the tumor presented as a circumscribed, multinodular or multicystic, hemorrhagic mass that ranged in size from 0.7 to 10 cm (median 2.5 cm). On microscopic examination, it consisted principally of 1) solid arrays or nests of fibroblast- and histiocyte-like cells, not infrequently containing varying amounts of intracellular hemosiderin or lipid, 2) focal areas of hemorrhage or hemorrhagic cyst-like spaces, sometimes occupying the major portion of the tumor, and 3) aggregates of chronic inflammatory cells, chiefly lymphocytes and plasmacytes, a feature that caused confusion with a lymph node metastasis in several cases. Follow-up information, available in 24 patients, revealed a variable clinical course. Twenty-one patients were alive, 11 with recurrence (including one with 9 recurrences in a 21-year period) one with recurrence and metastasis and one with metastasis. Three patients had died of metastasis 1, 3, and 13 years respectively, after the initial surgical therapy. The exact histogenesis is still obscure. Most likely it is a tumor of fibroblast- and histiocyte-like cells, akin to malignant fibrous histiocytoma, but different in its age incidence, microscopic appearance and behavior.
Cancer 1979 Dec
PMID:Angiomatoid malignant fibrous histiocytoma: a distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm. 22 36

Participants in a Nursing Mirror sponsored tour of China spent a day at the Tsinan Hospital and Medical College. They were permitted to watch 3 operations performed under traditional anesthesia. A thyroidictomy and removal of an ovarian cyst were performed under herbal anesthesia, and an operation for cancer of the esophagus was performed with acupuncture anesthesia. The patients were conscious throughout the procedures and appeared to be confortable. The herbal anesthesia was made by combining a substance derived from thorn apple flowers with a muscle relaxant. These traditional methods of anesthesia permitted the patients to cooperate with the surgeon during the operation. The patients suffered no after effects from the anesthesia, and the group was told that recovery time was shorter than when Western forms of anesthesia were used. The tour group also visited the nurses' training school and were informed that 1) there were 200 students currently enrolled in the school and 2) nursing training consisted of 1 1/2 years of academic work followed by 1/2 year of on the job training. The group discussed family planning services with hospital personnel and learned 1) IUD insertions were performed by trained midwives; 2) midwives conducted childbirth classes for pregnant women; 3) labor was induced primarily with herbal medicines; and 4) women were prepared to cope with labor pain through ideological education although acupuncture and pethidine were sometimes used to reduce pain.
 ...
PMID:NM goes to China:4. 24 56

Nutritional therapy of the cancer patient by the oral route includes management of factors that may cause anorexia, attempts to modify the patient's eating behavior, and the offering of nutritional supplements to the patient. Anoretic factors for which specific strategies may be employed include taste abnormalities, pain, nausea, and depression. Modification of the patient's eating behavior involves patient education, monitoring, and feedback. Education includes nutritional instruction and instruction in favorable patterns for mealtime eating and stimulation of snack eating. Snack eating includes the use of nutritional supplements, and patient acceptance of commercially available supplements was studied. When synthetic chemically defined nutritional products were compared with milk-based product, patients preferred the milk-based product. Intercomparisons between milk-based products showed slight differences in preference ranking among these products and also differences between patients and controls in their relative order of ranking. Preference testing may be useful in assisting the health care team in selecting the optimal nutritional supplement to offer each patient.
Cancer Res 1977 Jul
PMID:Oral feeding in the nutritional management of the cancer patient. 26 17

Based on characteristic case-reports the mostly occurring patterns of maxillo-facial pain are discussed. A description is given of pain in case of pulpitis, dento-alveolar abcess, dry socket, deep local periodonitis, temporomandibular joint arthrosis, dehiscence of the mandibular canal, maxillary sinusitis, malignant neoplasm. Trigeminal neuralgia, atypical facial neuralgia and psychogenic pains are discussed. The article concludes with a survey of the most important symptoms of these pain-syndromes in order to facilitate a correct diagnosis.
 ...
PMID:[Pain in the maxillofacial area: diagnosis and treatment]. 27 56

We have heard today that psychological factors are extremely important in pain problems and that careful psychiatric assessment should delineate patients who have the potential of achieving good pain relief with interventional procedures. The bulwarks of the neurosurgical management of pain have been peripheral neurectomy, rhizotomy, sympathectomy, and cordotomy. We have heard each of these discussed. Peripheral neurectomy and rhizotomies are not highly successful in the treatment of pain, but are useful in carefully chosen patients. Cordotomy remains an excellent technique for the management of many patients with chronic pain or malignancy, and sympathectomy can be one of the most gratifying operations performed, as long as the patients are well chosen. The major lesson we have learned today is that there is no cure for pain at the present time. Nevertheless, neurosurgical procedures remain an important part of pain management. They should be applied after an adequate diagnosis is made, after psychiatric characterization of the entire pain problem is complete, and only when there is only a definitive pain generator which can be relieved by an interventional procedure. Perhaps the most important message we have heard is the categorization of pain patients given us by Doctor Hendler. It is important that we all identify those patients with affective or exaggerated pain behavior so that interventional procedures are carried out only on those patients who have a real possibility of benefiting from them. I believe if we all do this, we will see a significant increase in the effectiveness of surgical procedures for pain.
 ...
PMID:Colloquium--is there a surgical cure for pain? 28 Apr 26

The two techniques of percutaneous cordotomy and pituitary injection of alcohol have been considered as methods applicable to the relief of intractable pain in inoperatable cancer. Percutaneous cordotomy is best indicated for unilateral pain below the C5 dermatome and will produce absolute relief of pain until death in up to 90% of patients. The injection of alcohol into the pituitary gives some relief of bilateral pain in about 70% of patients. Twenty percent obtain complete freedom from pain for up to 4 months, and 20% have complete freedom from pain for over 4 months. Both methods require the use of an image intensifier X-ray machine and care in observing safety precautions is necessary for both techniques. The pituitary injection of alcohol is the simpler of the two techniques. It can relieve bilateral cancer pain and it may be used to relieve pain in the head and neck of cancer sufferers which cannot be relieved by other methods.
 ...
PMID:Percutaneous cervical cordotomy and the injection of the pituitary with alcohol. 28 82

The pharmacokinetics and the hormonal, analgesic, and behavioral effects of several doses of human beta-endorphin were evaluated after intravenous administration to three patients and intracerebroventricular administration to one patient with pain caused by cancer. These effects were compared to the hormonal effects of intravenously administered morphine sulfate in two patients and an enkephalin analog in two baboons. The mean terminal half-life after intravenous administration of 5 or 10 mg of human beta-endorphin to three patients was 37 min; the mean volume of distribution was 178 ml/kg, and the metabolic clearance rate was 3.2 (ml/min)/kg. The half-life of beta-endorphin in cerebrospinal fluid after intracerebroventricular administration was 93 min, and the volume of distribution was 0.74 ml/kg. A rapid rise in plasma prolactin followed both intravenous and intracerebroventricular beta-endorphin. Intravenous administration did not affect plasma growth hormone, but intracerebroventricular administration suppressed plasma growth hormone. No significant change in plasma growth hormone was noted after intravenous administration of morphine to humans, but plasma growth hormone decreased in one baboon after administration of the enkephalin analog. beta-Endorphin-stimulated release of prolactin occurred at doses lower than those required to produce analgesic and other behavioral effects. When both hormonal and analgesic effects were observed (after 7.5 mg were given intracerebroventricularly), the onset of the hormonal response slightly preceded the analgesic and behavioral responses. These studies suggest that the hormonal effects of beta-endorphin are species dependent and are similar to those of morphine. Hormonal and analgesic effects of beta-endorphin appear to result from the activation of opiate receptors that differ in their locations and characteristics.
 ...
PMID:beta-Endorphin: analgesic and hormonal effects in humans. 29 54

Fifteen patients with cancer involving the temporal bone have been considered for radical surgical treatment by partial resection of the temporal bone during the past 12 years. All but one had undergone previous treatment by local surgery and/or irradiation. Two patients proved to be inoperable at surgical exploration. Three types of partial resection of the temporal bone and described to encompass disease involving the concha, the mastoid and squamous areas of the temporal bone, the ear canal, the middle ear, and the parotid gland. Closure of the surgical defect has been achieved in five cases using the residual pinna, in four cases with scalp flaps, and in five cases with a deltopectoral flap. Complications have been surprisingly few, with only one postoperative death. In one case communicating hydrocephalus persisted until death from residual disease many months later. Minor repair failure occurred in two patients. No attempt has been made to restore facial nerve function by grafting procedures. Long-term survival has been disappointing; however, it is considered that such radical surgery remains justified in selected cases for relief of the pain and disfigurement caused by chronic ulcerating neoplastic disease.
 ...
PMID:Temporal bone resection for cancer. 29 6


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>